RUNX1 and colorectal carcinoma: IHC analysis of 12 pairs of randomly selected CRC samples showed a positive correlation between the proportion of RUNX1 positive areas and CD68 (P < 0.0001), CD163 (P = 0.0002) positive areas in tumor (Fig. 1E-F).